MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-23-2026
Renalytix AI plc ROCE Ratio 2011-2026 | RNLX
Annual ROCE Ratio Renalytix AI plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 376.98 | -606.01 | -173.76 | -44.66 | -64.83 | -495.14 | 112.95 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 376.98 | -606.01 | -127.78 |
Quarterly ROCE Ratio Renalytix AI plc
| 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 799.92 | 872.37 | 1409.57 | 1240.64 | 535.87 | 365.06 | -231.12 | -404.88 | -393.98 | -315.48 | -272.97 | -143.87 | -104.54 | -84.36 | -129.48 | -579.96 | -456.92 | -447.01 | -64.83 | - | - | - | -495.14 | - | - | - | 112.95 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1409.57 | -579.96 | 57.71 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 89.49 | -3.22 % | $ 4.18 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 5.6 | -2.76 % | $ 7.45 M | USA |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 21.78 | 0.83 % | $ 631 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
63.01 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
-8.19 | $ 19.49 | -0.08 % | $ 600 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 129.26 | -2.86 % | $ 16.2 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.82 | $ 149.59 | -2.1 % | $ 11.7 B |  Irlanda |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 23.03 | -0.4 % | $ 1.23 B | USA |
 |
Illumina
ILMN
|
29.64 | $ 163.18 | -2.9 % | $ 25.3 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 167.59 | -1.09 % | $ 24.1 B |  Schweiz |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 103.0 | 0.17 % | $ 6.95 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 11.14 | -1.5 % | $ 1.43 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 183.53 | -1.23 % | $ 9.1 B | USA |
 |
Natera
NTRA
|
-18.1 | $ 218.16 | -1.78 % | $ 29.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 455.07 | -0.79 % | $ 13.1 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 19.63 | -0.61 % | $ 439 M | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.61 | -1.71 % | $ 427 M | USA |
 |
Personalis
PSNL
|
-33.71 | $ 11.4 | -5.79 % | $ 1.02 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 26.34 | 1.33 % | $ 25 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 7.03 | 0.21 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.09 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.15 | - | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 263.55 | 0.93 % | $ 21.9 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 69.6 | -5.86 % | $ 4.16 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 475.78 | -1.31 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.68 | -1.21 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.03 | -1.04 % | $ 1.96 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 199.38 | 1.64 % | $ 22.1 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
7.05 | $ 370.79 | -1.5 % | $ 22.1 B | USA |